AEMD Aethlon Medical, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$6,45
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,4152 haftanın en düşüğü
$41,5052 haftanın en yükseği
Piyasa Değeri (MRQ)
$3M
P/E
-0.1
Hisse Başına Kâr
$-10.61
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$1–$42
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$13
P/E
-0.1
ROE
-134.5%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
AEMD Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$6.45
Piyasa Değeri (MRQ)
$3M
P/E
-0.1
Hisse Başına Kâr
$-10.61
Gelir
$0
ROE
-134.5%
52 Haftlık Aralık
$1–$42
AEMD Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 04 Ağustos 2026 | 1-for-5 | Ters |
| 20 Ekim 2025 | 1-for-10 | Ters |
| 09 Haziran 2025 | 1-for-8 | Ters |
| 05 Ekim 2023 | 1-for-10 | Ters |
| 15 Ekim 2019 | 1-for-15 | Ters |
| 14 Nisan 2015 | 1-for-50 | Ters |
Aethlon Medical, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealth Care
endüstriHealth Care
çalışanlar9
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02021-03-31 → 2024-03-31
Hisse Başına Kâr$-10.612022-03-31 → 2026-03-31
Serbest Nakit Akışı$-7M2021-03-31 → 2026-03-31
Net kar marjı·2021-03-31 → 2023-03-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | AEMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.15Y ort. ≈-340.8 | ≈-340.8 | · | · | |
| P/S (F/S) | 118.45Y ort. ≈19244.7 | ≈19244.7 | 3.7 | Adil değer | |
| F/D (MRQ) | 0.65Y ort. ≈381.8 | ≈381.8 | 2.7 | Düşük değerli | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -0.35Y ort. ≈-599.7 | ≈-599.7 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -0.35Y ort. ≈-629.3 | ≈-629.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.45Y ort. ≈319.5 | ≈319.5 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | AEMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -104.5%5Y ort. ≈-96.8% | ≈-96.8% | -59.4% | Zayıf | |
| ROE | -134.5%5Y ort. ≈-142.6% | ≈-142.6% | -134.5% | Aynı seviyede | |
| ROIC | -149.3% | · | -176.5% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | AEMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 5.45Y ort. ≈6.7 | ≈6.7 | 1.8 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 3.55Y ort. ≈6.4 | ≈6.4 | 1.2 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | AEMD | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-206.7%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Mart 2027 | Ağu 13, 2026 | $-4.02 | $-0.80 | -402.1% |
| 30 Haziran 2026 | Ağu 13, 2026 | $-4.02 | $-0.80 | -402.1% |
| 31 Mart 2026 | $-1.49 | $-2.06 | 27.3% | |
| 31 Aralık 2025 | $-2.45 | $-2.47 | 0.75% | |
| 30 Eylül 2025 | $-3.74 | $-3.74 | -0.09% | |
| 30 Haziran 2025 | $-8.50 | $-8.77 | 3.1% | |
| 31 Mart 2025 | $-79.70 | $-10.30 | -673.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K | $886.6K | $762.4K | |
| R&D Expense | $2M | $2M | $3M | $3M | $2M | $2M | $927.0K | $896.0K | $586.0K | $673.0K | $782.0K | $1M | |
| SG&A Expense | $3M | $3M | $4M | $4M | $3M | $2M | $2M | $953.5K | $792.6K | $849.5K | $929.0K | $907.1K | |
| Operating Expenses | $7M | $9M | $13M | $12M | $11M | $9M | $7M | $6M | $5M | $6M | $5M | $5M | |
| Operating Income | $-7M | $-9M | $-13M | $-12M | $-10M | $-8M | $-6M | $-6M | $-5M | $-6M | $-4M | $-4M | |
| Interest Expense | · | $10.1K | · | · | · | · | · | · | · | · | $125.6K | $298.0K | |
| Interest Income | $156.5K | $298.1K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $142.2K | $-4M | · | · | · | $-1.6K | $-450.1K | $-220.5K | · | · | · | · | |
| Pretax Income | $-7M | $-13M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-13M | $-12M | $-12M | $-10M | $-8M | $-6M | $-6M | $-6M | $-7M | $-5M | $-7M | |
| EPS (Basic) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 673,945 | 156,085 | 314,097 | 2,053,744 | 14,756,967 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 673,945 | 156,085 | 314,097 | 2,053,744 | 14,756,967 | · | · | · | · | · | · | · | |
| EBITDA | $-7M | $-9M | · | $-12M | $-10M | $-8M | $-6M | $-6M | $-5M | $-6M | $-4M | $-4M |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $6M | $5M | $15M | $17M | $10M | $10M | $4M | $7M | $2M | $2M | $855.6K | |
| Receivables | · | · | · | $0 | $128.0K | $149.1K | $206.7K | $0 | $74.8K | $0 | $199.5K | $193.3K | |
| Prepaid Expense | $332.1K | $448.5K | $506.0K | $557.6K | $956.6K | $341.1K | $229.6K | $210.0K | $181.4K | $37.6K | $53.3K | $73.1K | |
| Current Assets | $6M | $6M | $6M | $15M | $18M | $10M | $10M | $4M | $7M | $2M | $2M | $1M | |
| PP&E (Net) | $356.8K | $676.2K | $1M | $1M | $441.2K | $161.0K | $140.5K | $6.0K | $27.6K | $29.2K | $36.0K | $56.1K | |
| PP&E (Gross) | $2M | $2M | $2M | $990.0K | $813.4K | $585.9K | $526.0K | $374.4K | $376.9K | $352.1K | $394.4K | $385.1K | |
| Accum. Depreciation | $1M | $978.9K | $990.5K | $734.2K | $493.9K | $424.9K | $385.5K | $368.3K | $349.4K | $322.9K | $358.4K | $329.0K | |
| Intangibles | $0 | $550 | $1.1K | $1.6K | $2.2K | $57.0K | $57.5K | $66.7K | $75.8K | $85.0K | $94.2K | $103.3K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $22.4K | $16.8K | |
| Total Assets | $6M | $7M | $8M | $18M | $19M | $11M | $10M | $4M | $7M | $2M | $3M | $1M | |
| Accounts Payable | $384.6K | $534.5K | $777.9K | $432.9K | $500.0K | $337.7K | $285.0K | $131.9K | $124.5K | $484.4K | $244.8K | $342.1K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $478.0K | $611.8K | $526.6K | $574.0K | |
| Capital Leases | $0 | $336.7K | $649.8K | $939.6K | $602.5K | $0 | $42.5K | $0 | · | · | · | · | |
| Total Liabilities | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $729.2K | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $314 | $259 | $329 | $2.3K | $15.4K | $12.2K | $9.4K | $1.3K | $17.7K | $8.8K | $7.6K | $6.7K | |
| Paid-in Capital | $180M | $173M | $160M | $157M | $147M | $129M | $121M | $108M | $106M | $94M | $88M | $82M | |
| Retained Earnings | $-175M | $-168M | $-155M | $-142M | $-130M | $-120M | $-112M | $-106M | $-99M | $-94M | $-87M | $-82M | |
| AOCI | $-32.7K | $-17.1K | $-6.9K | $-6.1K | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $5M | $5M | $6M | $15M | $17M | $9M | $9M | $2M | $6M | $676.4K | $2M | $615.5K | |
| Liabilities + Equity | $6M | $7M | $8M | $18M | $19M | $11M | $10M | $4M | $7M | $2M | $3M | $1M | |
| Shares Outstanding | 314,100 | 201,074 | 328,728 | 2,299,259 | 15,419,163 | 15,419,163 | 9,366,873 | 1,266,979 | 17,739,511 | 8,797,086 | 7,622,393 | 6,657,046 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $323.7K | $339.6K | $359.1K | $240.9K | $123.7K | $39.9K | $26.4K | $30.7K | $35.7K | $32.4K | $38.5K | $37.4K | |
| Stock-based Comp | $278.5K | $415.2K | $1M | $1M | $750.6K | $779.4K | $844.0K | $1M | $1M | $2M | $202.8K | $416.5K | |
| Amort. of Intangibles | $550 | $550 | $550 | $550 | $54.8K | $550 | $9.2K | $9.2K | $9.2K | $9.2K | $9.0K | $9.0K | |
| Other Non-cash | $-449.1K | $5M | · | $231.9K | $-225.4K | $302.4K | $306.0K | $551.6K | $472.5K | $2M | $301.7K | $1M | |
| Operating Cash Flow | $-7M | $-8M | $-10M | $-11M | $-10M | $-7M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | |
| CapEx | $3.7K | $0 | $250.9K | $943.1K | $349.2K | $59.9K | $151.7K | $0 | $24.8K | $16.4K | $9.3K | $0 | |
| Investing Cash Flow | $-3.7K | $0 | $-250.9K | $-943.1K | $-349.2K | $-59.9K | $-151.7K | $0 | $-24.8K | $-16.4K | $-9.3K | $0 | |
| Stock Issued | $7M | $5M | $1M | $9M | · | · | · | · | · | · | $6M | $5M | |
| Net Stock Activity | $7M | $4M | · | · | · | · | · | · | · | · | $6M | $5M | |
| Financing Cash Flow | $7M | $8M | $1M | $9M | $17M | $7M | $11M | $1M | $9M | $3M | $6M | $5M | |
| Net Change in Cash | $-473.7K | $69.6K | $-9M | $-3M | $7M | · | · | · | · | · | · | · | |
| Free Cash Flow | $-7M | $-8M | · | $-11M | $-10M | $-7M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -2072.1% | -3542.5% | -1197.1% | -912.0% | -2612.5% | -3228.8% | -1555.4% | -494.6% | -523.7% | |
| Net Margin | · | · | · | -2094.9% | -3540.9% | -1196.6% | -980.3% | -2697.8% | -3795.9% | -1855.8% | -549.6% | -891.5% | |
| EBITDA Margin | · | · | · | -2030.1% | -3500.5% | -1191.0% | -908.0% | -2599.2% | -3205.0% | -1547.2% | -490.2% | -518.8% | |
| ROA | -104.5% | -171.6% | · | -65.1% | -46.0% | -67.6% | -84.6% | -136.5% | -86.7% | -578.4% | -158.5% | -299.6% | |
| ROE | -134.5% | -283.1% | · | -74.4% | -78.4% | -83.7% | -107.7% | -144.8% | -166.8% | -652.8% | -449.4% | 94.8% | |
| ROIC | -149.3% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.1 | · | 10.0 | 10.0 | 7.5 | 9.4 | 2.2 | 15.1 | 2.6 | 4.6 | 2.1 | |
| Quick Ratio | 3.5 | 2.9 | · | 9.7 | 9.4 | 7.3 | 9.2 | 2.1 | 14.7 | 2.5 | 4.4 | 1.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | -924.1 | · | · | · | · | · | · | · | · | · | -11.4 |
Verimlilik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.3 | 0.3 | |
| Receivables Turnover | · | · | · | 9.0 | 2.1 | 3.7 | 6.3 | 6.1 | 4.0 | 3.9 | 4.5 | 5.3 |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.11 | $2.55 | · | $0.66 | $1.11 | $0.78 | $1.00 | $0.13 | $0.35 | $0.08 | $0.20 | $0.09 | |
| Revenue / Share | · | · | · | $0.03 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-10.38 | $-4.90 | · | $-0.51 | · | · | · | · | · | · | · | · | |
| Cash / Share | $3.20 | $2.74 | · | $0.63 | $1.11 | $0.81 | $1.03 | $0.20 | $0.39 | $0.18 | $0.28 | $0.13 | |
| EPS (TTM) | $-10.61 | $-8.58 | $-38.87 | $-5.86 | $-0.71 | · | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 95.2% | -55.4% | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17.1K | $17.1K | $0 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K | $886.6K | $762.4K | |
| Net Income TTM | $-7M | $-13M | $-12M | $-12M | $-10M | $-8M | $-6M | $-6M | $-6M | $-7M | $-5M | $-7M | |
| Market Cap | $3M | $58M | · | $6.99B | $18.01B | $19.73B | $11.39B | $216.65B | $253.32B | $345.20B | $490.27B | $918.67B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $918.67B | |
| P/E | -0.2 | -3.4 | -3.5 | -51.9 | -1645.1 | · | · | · | · | · | · | · | |
| P/S | 200.9 | 3383.1 | · | 12172.0 | 61222.7 | 29938.5 | 17518.8 | 943488.2 | 1693034.0 | 880442.3 | 552997.7 | 1204947.4 | |
| P/B | 0.7 | 11.3 | · | 464.0 | 1051.2 | 2092.4 | 1210.5 | 89335.6 | 41297.5 | 510361.3 | 315750.6 | 1492684.0 | |
| P / Tangible Book | 0.7 | 11.3 | 61.3 | 464.0 | 1060.1 | 2105.1 | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | -7.6 | · | -665.4 | -1843.9 | -2916.9 | -2191.5 | -50460.4 | -64776.5 | -98461.9 | -113245.0 | -181936.4 | |
| P / FCF | -0.5 | -7.6 | · | -610.5 | -1780.2 | -2891.3 | -2129.4 | -50460.4 | -64367.9 | -98002.6 | -113002.1 | -181936.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -232251.6 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | -181936.3 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1204946.2 | |
| Earnings Yield | -484.5% | -29.8% | -28.9% | -1.9% | -0.06% | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | $574.2K | $0 | $0 | |
| R&D Expense | $549.0K | $560.5K | $532.8K | $294.3K | $524.0K | $1M | $240.2K | $261.5K | $414.7K | $619.2K | $593.4K | $628.4K | $678.9K | $476.0K | $558.2K | $852.5K | |
| SG&A Expense | $662.5K | $698.0K | $741.6K | $521.4K | $735.4K | $716.4K | $816.4K | $958.4K | $752.0K | $764.9K | $979.2K | $850.8K | $1M | $829.1K | $1M | $2M | |
| Operating Expenses | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $4M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-2M | $-4M | $-3M | $-3M | $-2M | $-3M | $-4M | |
| Other Non-op | · | · | · | · | $-5.9K | · | · | · | $0 | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-2M | $-1M | $-2M | $-6M | $-2M | $-3M | $-3M | $-2M | $-3M | $-3M | $-3M | $-2M | $-3M | $-4M | |
| EPS (Basic) | $-4.02 | $-3.57 | $-2.45 | $-3.74 | $-42.42 | $-56.85 | $-10.05 | $-16.11 | $-2.76 | $-34.93 | $-1.37 | $-1.22 | $-1.35 | $-2.59 | $-1.24 | $-1.84 | |
| EPS (Diluted) | $-4.02 | $-3.57 | $-2.45 | $-3.74 | $-42.42 | $-56.85 | $-10.05 | $-16.11 | $-2.76 | $-34.93 | $-1.37 | $-1.22 | $-1.35 | $-2.59 | $-1.24 | $-1.84 | |
| Shares (Basic) | 384,705 | · | 823,126 | 397,513 | 41,529 | · | 174,529 | 174,220 | 932,248 | · | 2,516,511 | 2,483,649 | 2,431,476 | · | 2,294,649 | 2,074,500 | |
| Shares (Diluted) | 384,705 | · | 823,126 | 397,513 | 41,529 | · | 174,529 | 174,220 | 932,248 | · | 2,516,511 | 2,483,649 | 2,431,476 | · | 2,294,649 | 2,074,500 | |
| EBITDA | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-3M | $-4M |
Bilanço
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $5M | $7M | $6M | $4M | $6M | $5M | $7M | $9M | $5M | $8M | $10M | $13M | $15M | $17M | $20M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $114.8K | |
| Prepaid Expense | $283.1K | $332.1K | $185.1K | $182.1K | $276.6K | $448.5K | $88.3K | $279.0K | $478.1K | $506.0K | $277.3K | $311.4K | $410.2K | $557.6K | $672.8K | $784.6K | |
| Current Assets | $6M | $6M | $7M | $6M | $4M | $6M | $5M | $7M | $10M | $6M | $8M | $10M | $13M | $15M | $18M | $21M | |
| PP&E (Net) | $293.1K | $356.8K | $434.2K | $514.0K | $593.7K | $676.2K | $762.1K | $843.6K | $929.3K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $990.0K | · | · | |
| Accum. Depreciation | · | $1M | · | · | · | $978.9K | · | · | · | $990.5K | · | · | · | $734.2K | · | · | |
| Intangibles | · | $0 | $138 | $275 | $413 | $550 | $688 | $825 | $963 | $1.1K | $1.2K | $1.4K | $1.5K | $1.6K | $1.8K | $1.9K | |
| Total Assets | $6M | $6M | $8M | $7M | $5M | $7M | $7M | $9M | $11M | $8M | $10M | $13M | $16M | $18M | $21M | $23M | |
| Accounts Payable | $411.4K | $384.6K | $469.5K | $570.8K | $571.5K | $534.5K | $610.9K | $922.9K | $1M | $777.9K | $693.2K | $684.9K | $844.5K | $432.9K | $226.8K | $361.0K | |
| Current Liabilities | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | $0 | $86.9K | $172.1K | $255.1K | $336.7K | $417.5K | $496.8K | $573.9K | $649.8K | $724.8K | $798.5K | $869.9K | $939.6K | $1M | $1M | |
| Total Liabilities | · | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | |
| Common Stock | $477 | $1.6K | $973 | $761 | $2.6K | $259 | $14.0K | $14.0K | $13.9K | $329 | $2.6K | $2.5K | $24.8K | $2.3K | $23.0K | $22.9K | |
| Paid-in Capital | $182M | $180M | $180M | $177M | $173M | $173M | $166M | $166M | $166M | $160M | $160M | $159M | $159M | $157M | $157M | $157M | |
| Retained Earnings | $-177M | $-175M | $-173M | $-171M | $-170M | $-168M | $-162M | $-160M | $-157M | $-155M | $-152M | $-149M | $-146M | $-142M | $-140M | $-137M | |
| AOCI | $-38.9K | $-32.7K | $-29.8K | $-26.4K | $-22.4K | $-17.1K | $-17.0K | $-4.0K | $-7.8K | $-6.9K | $-1.6K | $-9.6K | $-7.1K | $-6.1K | · | · | |
| Stockholders' Equity | $5M | $5M | $7M | $6M | $3M | $5M | $4M | $6M | $9M | $6M | $8M | $10M | $13M | $15M | $17M | $20M | |
| Liabilities + Equity | $6M | $6M | $8M | $7M | $5M | $7M | $7M | $9M | $11M | $8M | $10M | $13M | $16M | $18M | $21M | $23M | |
| Shares Outstanding | 477,402 | 1,570,449 | 973,213 | 761,318 | 2,598,711 | 201,074 | 13,986,669 | 13,961,998 | 13,937,327 | 328,728 | 2,596,538 | 2,492,908 | 24,835,321 | 2,299,259 | 22,969,349 | 22,946,232 |
Nakit Akışı
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.9K | $79.5K | $81.6K | $79.9K | $82.6K | $83.9K | $83.8K | $85.8K | $86.1K | $85.8K | $91.5K | $91.4K | $90.3K | $79.5K | $78.1K | $52.6K | |
| Stock-based Comp | $50.0K | $61.2K | $72.4K | $72.4K | $72.4K | $72.4K | $90.0K | $113.5K | $139.3K | $139.1K | $573.0K | $257.2K | $250.1K | $260.3K | $262.6K | $313.5K | |
| Other Non-cash | $-471.5K | · | · | · | $-108.2K | · | · | · | $598.5K | · | · | · | $459.4K | · | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $-3M | |
| CapEx | $9.2K | $2.1K | · | · | $0 | $-2.2K | $2.2K | $0 | $0 | $4.9K | $8.8K | $6.8K | $230.4K | $11.3K | $151.5K | $739.2K | |
| Investing Cash Flow | $-9.2K | $-2.1K | · | · | $0 | $2.2K | $-2.2K | $0 | $0 | $-4.9K | $-8.8K | $-6.8K | $-230.4K | $-11.3K | $-151.5K | $-739.2K | |
| Stock Issued | $2M | $-848.5K | $4M | $4M | $0 | $-680.5K | $0 | $0 | $4M | $49.8K | $186.5K | $0 | $1M | $0 | $0 | $8M | |
| Net Stock Activity | $2M | · | · | · | $0 | · | · | · | $4M | · | · | · | $1M | · | · | · | |
| Financing Cash Flow | $2M | $-196.5K | $3M | $4M | $-5.4K | $2M | $-7.1K | $-3.8K | $5M | $42.6K | $177.1K | $-9.8K | $1M | $-2.6K | $-1.9K | $8M | |
| Net Change in Cash | $-92.7K | $-2M | $1M | $2M | $-2M | $686.2K | $-2M | $-2M | $4M | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $5M | |
| Free Cash Flow | $-2M | · | · | · | · | · | · | · | $-2M | · | · | · | $-3M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5047.0% | · | -4700.4% | -6642.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -4947.0% | · | -4600.4% | -6542.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4814.1% | · | -4700.4% | -6642.4% | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -26.8% | · | -27.7% | -18.4% | -21.1% | · | -20.7% | -25.9% | -18.9% | · | -22.2% | -16.9% | -19.9% | · | -13.4% | · | |
| ROE | -35.9% | · | -36.5% | -25.3% | -29.0% | · | -29.4% | -34.4% | -23.6% | · | -27.9% | -20.1% | -23.3% | · | -15.0% | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | · | 5.7 | 4.5 | 2.5 | · | 2.8 | 3.1 | 4.5 | · | 3.9 | 6.1 | 7.3 | · | 7.5 | 9.8 | |
| Quick Ratio | 4.8 | · | 5.5 | 4.2 | 2.3 | · | 2.7 | 2.9 | 4.3 | · | 3.8 | 5.9 | 7.1 | · | 7.2 | 9.4 |
Verimlilik
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.89 | · | $6.90 | $7.55 | $1.32 | · | $0.31 | $0.43 | $0.63 | · | $2.93 | $4.14 | $0.53 | · | $0.75 | $0.87 | |
| Revenue / Share | $0.08 | · | $0.05 | $0.06 | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | |
| Cash Flow / Share | $-4.93 | · | · | · | $-0.83 | · | · | · | $-0.23 | · | · | · | $-0.10 | · | · | · | |
| Cash / Share | $10.33 | · | $7.15 | $7.69 | $1.45 | · | $0.34 | $0.49 | $0.65 | · | $3.07 | $4.08 | $0.52 | · | $0.76 | $0.85 | |
| EPS (TTM) | $-13.78 | · | $-105.46 | $-113.06 | $-125.43 | · | $-63.85 | $-55.17 | $-40.28 | · | $-6.53 | $-6.40 | $-7.02 | · | $-3.53 | $-2.45 |
Değerleme (TTM)
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $574.2K | · | $574.2K | $574.2K | $574.2K | · | $574.2K | $574.2K | $574.2K | · | $574.2K | $574.2K | $574.2K | · | $13.1K | $30.2K | |
| Net Income TTM | $-7M | · | $-12M | $-11M | $-13M | · | $-10M | $-11M | $-11M | · | $-12M | $-12M | $-12M | · | $-13M | $-13M | |
| Market Cap | $391.5K | · | $3M | $6M | $31M | · | $962M | $525M | $557M | · | $455M | $459M | $7.15B | · | $5.15B | $10.65B | |
| P/E | -0.3 | · | -0.1 | -0.3 | -0.5 | · | -5.4 | -3.4 | -5.0 | · | -134.2 | -143.8 | -205.1 | · | -317.3 | -946.9 | |
| P/S | 3.4 | · | 23.5 | 49.7 | 271.5 | · | 8378.7 | 4571.0 | 4854.1 | · | 3961.0 | 3993.9 | 62278.1 | · | 1961396.1 | 1760832.8 | |
| P/B | 0.1 | · | 0.4 | 1.0 | 9.1 | · | 222.0 | 87.2 | 64.0 | · | 59.8 | 44.5 | 545.6 | · | 297.8 | 535.9 | |
| P / Tangible Book | 0.1 | · | 0.4 | 1.0 | 9.1 | · | 222.1 | 87.2 | 64.0 | · | 59.8 | 44.5 | 545.7 | · | 297.8 | 535.9 | |
| P / Cash Flow | -0.2 | · | · | · | -18.2 | · | · | · | -319.0 | · | · | · | -2881.3 | · | · | · | |
| Earnings Yield | -336.1% | · | -761.4% | -301.5% | -209.1% | · | -18.6% | -29.3% | -20.1% | · | -0.75% | -0.70% | -0.49% | · | -0.32% | -0.11% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Gelir | · | · | $0 | $574.2K | $294.2K |
| Faaliyet Kâr Marjı % | · | · | · | -2072.1% | -3542.5% |
| Net Gelir | $-7M | $-13M | $-12M | $-12M | $-10M |
| Seyreltilmiş Hisse Başı Kâr | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Cari Oran | 3.8 | 3.1 | · | 10.0 | 10.0 |
| Cari Oran | 3.5 | 2.9 | · | 9.7 | 9.4 |
| Metrik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-7M | $-8M | · | $-11M | $-10M |
Kurumsal Sahipler (13F) 17 dosya · $136K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
17
Tutulan Değer
$136K
Yeni pozisyonlar
7
Çıkan pozisyonlar
2
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 7 (+1 önceki Ç'ye göre) | 2 (0 önceki Ç'ye göre) | 4 (+4 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | +195K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $35.387 | 42.977 | 25,99% | Hisse senetleri |
| JANE STREET GROUP, LLC | $32.014 | 38.880 | 23,51% | Hisse senetleri |
| Shay Capital LLC | $25.585 | 31.072 | 18,79% | Hisse senetleri |
| Ikarian Capital, LLC | $11.827 | 14.364 | 8,69% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $8.389 | 10.189 | 6,16% | Hisse senetleri |
| Scientech Research LLC | $8.278 | 10.054 | 6,08% | Hisse senetleri |
| UBS Group AG | $7.305 | 8.876 | 5,37% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $5.213 | 6.331 | 3,83% | Hisse senetleri |
| MORGAN STANLEY | $2.035 | 2.472 | 1,49% | Hisse senetleri |
| HRT FINANCIAL LP | $59 | 72.743 | 0,04% | Hisse senetleri |
| Virtu Financial LLC | $23 | 27.815 | 0,02% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $15 | 17 | 0,01% | Hisse senetleri |
| GROUP ONE TRADING LLC | $12 | 14 | 0,01% | Hisse senetleri |
| BlackRock, Inc. | $8 | 10 | 0,01% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $2 | 3 | 0,00% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $2 | 2 | 0,00% | Hisse senetleri |
| DANSKE BANK A/S | $1 | 1 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Ellen R. Weiner Family Revocable Trust | 18 Şubat 2015 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 16 Aralık 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 16 Aralık 2005 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 23 Kasım 2005 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 23 Kasım 2005 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 17 içeriden öğrenenler · 9 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Charles J Fisher JR | Chief Executive Officer | 10 Şubat 2022 A | 19.569 | 0 | 0 | $0 |
| Timothy C Rodell JR | Chief Executive Officer | 03 Nisan 2020 A | · | 0 | 0 | $0 |
| James A Joyce | Chairman, CEO, Secretary | 31 Ekim 2018 C | 212.370 | 0 | 0 | $0 |
| James B Frakes | CFO & Sr. VP ? Finance | 10 Şubat 2022 A | 2.483 | 0 | 0 | $0 |
| Rodney S Kenley | President | 31 Ekim 2018 C | 20.358 | 0 | 0 | $0 |
| Lee D Arnold | Chief Scientific Officer | 01 Şubat 2023 A | · | 0 | 0 | $0 |
| Steven P Larosa | Chief Medical Officer | 10 Şubat 2022 A | · | 0 | 0 | $0 |
| Guy F. Cipriani | Sr. V.P., Chief Bus. Officer | 10 Şubat 2022 A | 17.901 | 0 | 0 | $0 |
| Richard Tullis | VP, CHIEF SCIENCE OFFICER | 06 Haziran 2014 A | 526.750 | 0 | 0 | $0 |
| Nicolas Gikakis | Yönetim kurulu üyesi | 30 Haziran 2026 F | 20.663 | 0 | 0 | $0 |
| Chetan Shah | Yönetim kurulu üyesi | 30 Haziran 2026 F | 20.840 | 0 | 0 | $0 |
| Edward G Broenniman | Yönetim kurulu üyesi | 30 Haziran 2026 F | 22.363 | 0 | 0 | $0 |
| Angela Rossetti | Yönetim kurulu üyesi | 17 Nisan 2026 A | 26.207 | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Yönetim kurulu üyesi | 31 Mart 2022 F | 33.642 | 0 | 0 | $0 |
| Franklyn S Barry JR | Yönetim kurulu üyesi | 30 Eylül 2016 M | 10.340 | 0 | 0 | $0 |
| Phillip A Ward | · | 14 Mart 2014 A | · | 0 | 0 | $0 |
| Calvin M Leung | · | 23 Şubat 2005 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
AEMD Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
SAT
Medyan hedef
$13.25
+105,4%
0 0,0%
Güçlü Al
0 0,0%
Al
4 57,1%
Tut
1 14,3%
Sat
2 28,6%
Güçlü Sat
12 Aylık Fiyat Hedefi
2 analist · 2026-09-28Ortalama hedef $13.25 +105,4%
Şimdi
Mevcut fiyat $6.45
Düşük$1.50
Ortalama$13.25
Yüksek$25.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| AEMD | $3M | -0.2 | · | · | -134.5% | · |
| SINT | $15M | -0.6 | -64.7% | -1018.1% | -299.7% | 45.3% |
| CTSO | · | -4.9 | 4.1% | · | · | · |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| BMRA | · | -1.8 | -16.2% | · | · | · |
| NMTC | · | -9.9 | 163.5% | · | · | · |
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026